Operating Income: The income after operating expenses.
Ascendis Pharma A/S (ASND) had Operating Income of $256.33M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$394.49M |
|
$240.64M |
|
$32.16M |
|
$362.33M |
|
$138.15M |
|
|
Operating Income |
$256.33M |
$11.19M |
|
$267.53M |
|
$267.53M |
|
$240.64M |
|
$240.64M |
|
$240.64M |
|
$240.64M |
|
$256.33M |
|
$261.61M |
|
64.34M |
|
68.32M |
|
$3.74 |
|
$3.29 |
|
| Balance Sheet Financials | |
$1.62B |
|
$157.76M |
|
$1.04B |
|
$2.66B |
|
$540.52M |
|
$447.22M |
|
$447.22M |
|
$987.75M |
|
$1.67B |
|
$1.67B |
|
$1.67B |
|
65.67M |
|
| Cash Flow Statement Financials | |
$318.53M |
|
$-11.17M |
|
$-96.45M |
|
$716.27M |
|
$944.41M |
|
$228.14M |
|
$69.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.99 |
|
-- |
|
-- |
|
0.21 |
|
0.31 |
|
91.85% |
|
64.98% |
|
64.98% |
|
-- |
|
67.82% |
|
61.00% |
|
$305.81M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.09 |
|
1.51 |
|
59.45 |
|
14.41% |
|
14.45% |
|
9.05% |
|
11.36% |
|
$25.43 |
|
$4.48 |
|
$4.66 |
|